IN
Item 9 Labs Corp.
INLB · OTC
$0.00 +0.00% (+$0.00)
Market Cap $70.2K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
3/9Valuation
100 /100
Cheap P/S 0.00x
P/B 0.00x
P/E N/A
Growth
100 /100
Growing Rev. growth 63.98%
Book val. growth 102.51%
EPS growth N/A
Profitability
13 /100
Weak Gross margin 33.61%
Net margin 143.14%
Op. margin 106.01%
Quality
3 /100
Poor ROIC 25.60%
ROA 28.12%
Asset turnover 0.20x
Debt
61 /100
Moderate Debt/Equity 0.45x
Current ratio 0.09x
Int. coverage -3.86x
Stability
1 /100
Unstable Beta 0.14x
Rev. volatility 86.24%
EPS volatility 85.31%
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre INLB
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Jeffrey I. Rassas
Employees
97
Headquarters
Phoenix
Evenimente viitoare
02 DEC.
Earnings
Upcoming earnings report